11 completed, 7 recruiting, 5 active not recruiting, 5 unknown. 14 Not applicable, 9 Phase 2, 5 Phase 1, 3 Early Phase 1, 1 Phase 3.
Follow Colon Carcinoma: new trials by email Literature Review of Colon Carcinoma trials Research Report on Colon Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Zanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for Curative Intent Treatment Zanidatamab, Resection, Patient Observation - Colon Carcinoma, Colorectal Carcinoma | Phase 2 | Recruiting | Emory University | 38 | 2026-04-07 | 2026-04-17 |
| Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays PAGODA algorithm, Oxaliplatin, Folinic Acid - Ampulla of Vater Carcinoma, Appendix Carcinoma | Not applicable | Recruiting | Alliance for Clinical Trials in Oncology | 420 | 2026-02-13 | 2026-11-04 |
| Phytocannabinoids for Reducing Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors Biospecimen Collection, Cannabidiol, Dronabinol - Breast Carcinoma, Chemotherapy-Induced Peripheral Neuropathy | Phase 2 | Recruiting | City of Hope Medical Center | 120 | 2025-10-03 | 2025-12-05 |
| Pre-Operative Treatment in REseCTable COlon CanceR mFOLFOXIRI, mFOLFOX-6, CAPOX - Colo-rectal Cancer, Colon Cancer | Phase 3 | Not yet recruiting | Dominik Paul Modest | 714 | 2025-04-01 | 2025-03-28 |
| PET-imaging of Two Vartumabs in Patients With Solid Tumors 89Zr-DFO-N-Suc-F8scFv, 89Zr-DFO-N-Suc-C9scFv, PET/CT scan - Solid Tumor, Colon Carcinoma | Early Phase 1 | Recruiting | Var2 Pharmaceuticals | 32 | 2024-12-10 | 2025-12-29 |
| Phytocannabinoids for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors Cannabidiol, Delta-8-Tetrahydrocannabinol, Placebo Administration - Breast Carcinoma, Chemotherapy-Induced Peripheral Neuropathy | Early Phase 1 | Withdrawn | City of Hope Medical Center | 2024-07-06 | 2024-08-09 | |
| Encorafenib + Cetuximab Beyond Progression in Combination With FOLFIRI in Patients With BRAF V600E Mutated Metastatic Colorectal Cancer Progressing on Encorafenib + Cetuximab. encorafenib + cetuximab + FOLFIRI - Colorectal Carcinoma, Colorectal Neoplasms | Phase 2 | Recruiting | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 25 | 2024-06-03 | 2025-02-12 |
| Safety and Feasibility of Immuno-OCT Bevacizumab-800CW - Colon Carcinoma, Barrett Esophagus | Not applicable | Unknown | University Medical Center Groningen | 15 | 2024-04-01 | 2024-03-20 |
| Trained Immunity in Thyroid Carcinoma and Colon Carcinoma no intervention will take place - Thyroid Cancer, Nonmedullary, Colon Carcinoma | Completed | Radboud University Medical Center | 33 | 2022-09-19 | 2025-12-09 | |
| Validation Study on the Removal of EpCAM-positive Tumour Cells From Blood Collected During Tumour Surgery Using Catumaxomab/Catuvab Device CATUVAB - Bladder Carcinoma, Prostate Tumor | Not applicable | Completed | Lindis Bloodcare GmbH | 136 | 2022-02-15 | 2025-01-23 |
| Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal Cancer Acupuncture Therapy, Acupressure Therapy, Oral Cryotherapy - Appendix Carcinoma, Colon Carcinoma | Phase 2 | Completed | University of Washington | 78 | 2021-06-01 | 2026-01-21 |
| Lymph Node Mapping Via Flourescent Dye in Colon Cancer ICG-marking endoscopically - Colon Carcinoma, Lymph Node Metastases | Not applicable | Recruiting | Universitätsklinikum Hamburg-Eppendorf | 30 | 2021-05-31 | 2023-05-23 |
| Clinical Outcomes for Offering Genetic Testing in a Tiered Approach Electronic Health Record Review, Questionnaire Administration, Behavioral Intervention - Breast Carcinoma, Colon Carcinoma | Not applicable | Completed | Fred Hutchinson Cancer Center | 6 | 2020-08-03 | 2023-06-09 |
| Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues Computed Tomography, Gallium Ga 68 FAPi-46, Gallium Ga 68-labeled PSMA-11 - Breast Carcinoma, Colon Carcinoma | Early Phase 1 | Active not recruiting | Jonsson Comprehensive Cancer Center | 29 | 2019-11-05 | 2026-08-21 |
| Nivolumab in Preventing Colon Adenomas in Participants With Lynch Syndrome and a History of Partial Colectomy Nivolumab - Colon Adenoma, Colon Carcinoma | Phase 2 | Terminated | John Hays | 3 | 2018-10-04 | 2024-07-01 |
| Phase I Trial of Universal Donor NK Cell Therapy in Combination With ALT803 Natural Killer (NK) Cells, ALT803 - Acute Myeloid Leukemia, Myelodysplastic Syndrome | Phase 1 | Completed | Brenda Cooper, MD | 14 | 2018-05-22 | 2023-02-21 |
| Social Media Listening in Improving Clinical Trial Recruitment in Patients With Cancer Internet-Based Intervention, Survey Administration - Breast Carcinoma, Colon Carcinoma | Not applicable | Withdrawn | University of Southern California | 2017-11-08 | 2019-09-17 | |
| The Assessment of the Feasibility of a Home Based Exercise Programme in the Older Patient Following Major Surgery Exercise Programme - Impaired Cognition, Quality of Life | Not applicable | Completed | University of Nottingham | 11 | 2017-06-26 | 2019-04-17 |
| Lesion Detection Assessment in the Liver: Standard vs Low Radiation Dose Using Varied Post-Processing Techniques Computed Tomography Scan - 50% Dose Reduction, Computed Tomography Scan - 70% Dose Reduction, Deep Learning Image Reconstruction (DLIR) - Diseases of Liver, Colon Carcinoma | Not applicable | Active not recruiting | M.D. Anderson Cancer Center | 146 | 2017-05-09 | 2026-09-14 |
| Neoadjuvant Immune Checkpoint Inhibition and Novel IO Combinations in Early-stage Colon Cancer Nivolumab, Ipilimumab, Celecoxib 200mg - Colon Carcinoma | Phase 2 | Recruiting | The Netherlands Cancer Institute | 353 | 2017-03-29 | 2026-09-30 |
Showing 20 of 35. Sign in to see all of them.
Colonic Neoplasms (35) · Rectal Neoplasms (11) · Breast Neoplasms (10) · Pancreatic Neoplasms (9) · Carcinoma, Renal Cell (8) · Carcinoma, Hepatocellular (7) · Colorectal Neoplasms (7) · Prostatic Neoplasms (7) · Stomach Neoplasms (6) · Urinary Bladder Neoplasms (6) · Esophageal Neoplasms (5) · Lung Neoplasms (5) · Ovarian Neoplasms (5) · Carcinoma, Non-Small-Cell Lung (4) · Melanoma (4)
Colonic Diseases (35) · Digestive System Neoplasms (35) · Gastrointestinal Diseases (35) · Intestinal Diseases (35) · Neoplasms by Site (35) · Digestive System Diseases (34) · Intestinal Neoplasms (34) · Gastrointestinal Neoplasms (33) · Neoplasms (32) · Colorectal Neoplasms (28) · Rectal Diseases (16) · Neoplasms by Histologic Type (14) · Carcinoma (13) · Neoplasms, Glandular and Epithelial (13) · Female Urogenital Diseases (12)
Specimen Handling (4) · Fluorouracil (3) · Leucovorin (3) · Magnetic Resonance Spectroscopy (3) · Nivolumab (3) · Oxaliplatin (3) · Biopsy (2) · Cannabidiol (2) · X-Rays (2) · relatlimab (2) · 2-(3-(2-(1-isopropyl-3-methyl-1H-1,2-4-triazol-5-yl)-5,6-dihydrobenzo(f)imidazo(1,2-d)(1,4)oxazepin-9-yl)-1H-pyrazol-1-yl)-2-methylpropanamide (1) · 2C4 antibody (1) · 68Ga-DKFZ-PSMA-11 (1) · ALT-803 (1) · AZD4547 (1)
National Cancer Institute (NCI) (4) · City of Hope Medical Center (3) · University of Southern California (2) · Alliance for Clinical Trials in Oncology (1) · Barbara Ann Karmanos Cancer Institute (1) · Brenda Cooper, MD (1) · Dominik Paul Modest (1) · Emory University (1) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1) · Fred Hutchinson Cancer Center (1) · John Hays (1) · Jonsson Comprehensive Cancer Center (1) · Lindis Bloodcare GmbH (1) · M.D. Anderson Cancer Center (1) · Medical Center Alkmaar (1)
United States (20) · Netherlands (5) · Germany (4) · Guam (2) · Puerto Rico (2) · Austria (1) · Israel (1) · Italy (1) · United Kingdom (1)
Alexander PJ Houdijk, MD,PhD (1) · Anke B Smits, MD (1) · Anthony Shields, M.D. PhD (1) · Anurag Singh (1) · Bethan Phillips, BSc PhD (1) · Carl Christoph Schimanski, Prof. Dr. (1) · Christine D Berg (1) · Corey T. Jensen, MD (1) · Daniel Perez, Prof. Dr. (1) · David Wald, MD, PhD (1) · Dominik Modest, Prof. Dr. med. (1) · Gabriel A. Brooks, MD, MPH (1) · Gooitzen van Dam, MD, PhD (1) · Jeremie Calais, MD (1) · John Hays, MD, Ph.D (1)
PMID 17272566, PMID 18172738, PMID 18512998, PMID 18807433, PMID 19433843, PMID 19948388, PMID 21555753, PMID 24365071, PMID 26269366, PMID 26458331, PMID 26559156, PMID 26586415, PMID 30274964, PMID 30480489, PMID 32000810, PMID 32251400, PMID 32463741, PMID 32923171, PMID 32939319, PMID 33048619, PMID 33277073, PMID 34548240, PMID 34606846, PMID 34842538, PMID 35014900, PMID 35133871, PMID 35138919, PMID 36351402, PMID 36512649, PMID 37053535, PMID 37322121, PMID 37934000, PMID 38591867, PMID 38741776, PMID 38838311, PMID 38838316, PMID 39278994, PMID 39666929, PMID 39693587, PMID 39913886, PMID 40865033, PMID 41066729, PMID 41101974, PMID 41115454, PMID 41261199, PMID 41857556
2023 (2), P30CA014089 (2), P30CA015704 (2), P30CA033572 (2), N01CN35157 (1), P30CA060553 (1), P30CA138292 (1), R21CA260447 (1), U10CA180820 (1), U24CA196172 (1)